Corbus Pharmaceuticals Holdings, Inc. (CRBP)
7.14
-0.31
(-4.16%)
USD |
NASDAQ |
Sep 25, 16:00
7.16
+0.02
(+0.28%)
After-Hours: 19:59
Corbus Pharmaceuticals Holdings Price to Book Value : 1.304 for Sept. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 1.304 |
| September 24, 2026 | 1.360 |
| September 23, 2026 | 1.414 |
| September 22, 2026 | 1.438 |
| September 21, 2026 | 1.397 |
| September 18, 2026 | 1.366 |
| September 17, 2026 | 1.326 |
| September 16, 2026 | 1.326 |
| September 15, 2026 | 1.264 |
| September 14, 2026 | 1.476 |
| September 11, 2026 | 1.483 |
| September 10, 2026 | 1.505 |
| September 09, 2026 | 1.618 |
| September 08, 2026 | 1.935 |
| September 04, 2026 | 2.024 |
| September 03, 2026 | 2.093 |
| September 02, 2026 | 2.096 |
| September 01, 2026 | 2.06 |
| August 31, 2026 | 1.992 |
| August 28, 2026 | 1.992 |
| August 27, 2026 | 2.033 |
| August 26, 2026 | 2.064 |
| August 25, 2026 | 2.066 |
| August 24, 2026 | 1.952 |
| August 21, 2026 | 1.896 |
| Date | Value |
|---|---|
| August 20, 2026 | 1.797 |
| August 19, 2026 | 1.824 |
| August 18, 2026 | 1.841 |
| August 17, 2026 | 1.916 |
| August 14, 2026 | 1.843 |
| August 13, 2026 | 1.841 |
| August 12, 2026 | 1.782 |
| August 11, 2026 | 1.737 |
| August 10, 2026 | 1.728 |
| August 07, 2026 | 1.857 |
| August 06, 2026 | 1.779 |
| August 05, 2026 | 1.748 |
| August 04, 2026 | 1.717 |
| August 03, 2026 | 1.629 |
| July 31, 2026 | 1.638 |
| July 30, 2026 | 1.653 |
| July 29, 2026 | 1.629 |
| July 28, 2026 | 1.659 |
| July 27, 2026 | 1.658 |
| July 24, 2026 | 1.675 |
| July 23, 2026 | 1.702 |
| July 22, 2026 | 1.614 |
| July 21, 2026 | 1.64 |
| July 20, 2026 | 1.624 |
| July 17, 2026 | 1.645 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.724 |
| Alnylam Pharmaceuticals, Inc. | 25.28 |
| Anika Therapeutics, Inc. | 1.986 |
| Savara, Inc. | 7.149 |
| Vericel Corp. | 5.491 |
Price to Book Value Related Metrics
| PEG Ratio | -0.039 |
| Price | 7.14 |
| Earnings Yield | -86.51% |
| Market Cap | 133.31M |
| PEGY Ratio | -0.039 |